Cochlear implantation after bacterial meningitis in infants younger than 9 months

B Y Roukema1, M C Van Loon, C Smits

  • 1Department of Otolaryngology and Head and Neck Surgery, VU University Medical Center Amsterdam, KNO ZH1D-116, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands.

Insights

Cochlear implantation in infants after bacterial meningitis is challenging but feasible. Outcomes vary, requiring specialized audiological, anesthesiological, and surgical approaches for profound hearing loss.

Area of Science:

  • Otolaryngology
  • Pediatric Neurosurgery
  • Infectious Diseases

Background:

  • Bacterial meningitis can cause profound hearing loss in infants.
  • Early cochlear implantation is crucial for auditory development in affected infants.

Purpose of the Study:

  • To outline key audiological, anesthesiological, and surgical considerations for cochlear implantation in infants post-bacterial meningitis.
  • To discuss the challenges and outcomes associated with this procedure in a very young population.

Main Methods:

  • Retrospective analysis of 4 infants (4-8 months old) who received 7 cochlear implants between 2005-2010 after pneumococcal meningitis.
  • Evaluation of audiological outcomes using Categories of Auditory Performance (CAP) and Speech Intelligibility Rating (SIR) scores.

Main Results:

  • Successful full electrode insertion was achieved in all implanted ears.
  • Auditory and linguistic outcomes showed considerable variability, with CAP scores ranging from 3 to 6 and SIR scores from 0 to 5.
  • Specific audiological, anesthesiological, and surgical challenges were identified.

Conclusions:

  • Cochlear implantation in very young infants following meningitis is complex due to age, disease sequelae, and risk of cochlear obliteration.
  • A rapid diagnostic process and tailored management strategies are essential.
  • Outcomes are variable despite successful implantation.